A Review of 177Lutetium-PSMA and 225Actinium-PSMA as Emerging Theranostic Agents in Prostate Cancer

Authors :: Mohammad R, Alam
Shashi B, Singh
Shreeya, Thapaliya
Shreeya, Shrestha
Sulav, Deo
Kishor, Khanal
Source :: Cureus.
Publication Year :: 2022
Publisher :: Cureus, Inc., 2022.
Abstract: The development of prostate-specific membrane antigen (PSMA) ligands labeled with radionuclides is a ground-breaking achievement in the management of prostate cancer. With the increasing use of

Tools